Literature DB >> 33648690

Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga, Colombia.

Carlos Arturo Cassiani-Miranda1, Angy Karina Cuadros-Cruz2, Harold Torres-Pinzón3, Orlando Scoppetta4, Jhon Henrry Pinzón-Tarrazona5, Wendy Yulieth López-Fuentes5, Andrea Paez2, Diego Fernando Cabanzo-Arenas6, Sergio Ribero-Marulanda5, Elkin René Llanes-Amaya7.   

Abstract

The patient health questionnaire-9 (PHQ-9) is one of the most widely used self-report instruments in primary care. There is no criterion validity of the PHQ-9 in Colombia. The objective was to validate the PHQ-9 as a screening tool in primary care. A cross-sectional, scale criterion validity study was performed using as reference criterion the mini neuropsychiatric interview (MINI) in male and female adult users of primary care centres. We calculated the internal consistency and convergent and criterion validity of the PHQ-9 by analysing the receiver operating characteristics (ROC) and the area under the curve (AUC). We analysed 243 participants; 184 (75.7%) were female. The average age was 34.05 (median of 31 and SD = 12.47). Cronbach's α was 0.80 and McDonald's ω was 0.81. Spearman's Rho was 0.64 for HADS-D (P <0.010) and 0.70 for PHQ-2 (P <0.010). The AUC was 0.92 (95% CI 0.880-0.963). The optimal cut-off point of PHQ-9 was ≥7: sensitivity of 90.38 (95% CI: 81.41-99.36); specificity of 81.68 (95% CI: 75.93-87.42); PPV 57.32 (95% CI: 46.00-68.63); NPV 96.89 (95% CI: 93.90-99.88); Youden index 0.72 (95% CI: 0.62-0.82); LR+ 4.93 (95% CI: 3.61-6.74); LR- 0.12 (95% CI: 0.005-0.270). In sum, the Colombian version of PHQ-9 is a valid and reliable instrument for depression screening in primary care in Bucaramanga, with a cut-off point ≥7.
Copyright © 2019 Asociación Colombiana de Psiquiatría. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Atención primaria de salud; Colombia; Cribado; Depresión; Depression; PHQ-9; Primary healthcare; Reproducibilidad de los resultados; Reproducibility of results; Screening

Year:  2020        PMID: 33648690     DOI: 10.1016/j.rcp.2019.09.001

Source DB:  PubMed          Journal:  Rev Colomb Psiquiatr (Engl Ed)        ISSN: 2530-3120


  4 in total

1.  [PHQ-9 in screening of major depressive episode among COVID-19 survivors].

Authors:  Adalberto Campo-Arias; John Carlos Pedrozo-Pupo; Zuleima Cogollo-Milanés
Journal:  Rev Colomb Psiquiatr       Date:  2021-07-02

2.  Relationships Between Depressive Symptoms, Dietary Inflammatory Potential, and Sarcopenia: Mediation Analyses.

Authors:  Guo-Qiang Chen; Gang-Pu Wang; Ying Lian
Journal:  Front Nutr       Date:  2022-02-17

3.  Mental Health Disturbance after a Major Earthquake in Northern Peru: A Preliminary, Cross-Sectional Study.

Authors:  Mario J Valladares-Garrido; Luis E Zapata-Castro; Helena Domínguez-Troncos; Abigaíl García-Vicente; Darwin A León-Figueroa; J Pierre Zila-Velasque; Pamela Grados-Espinoza; David Astudillo-Rueda; C Ichiro Peralta; Cristian Díaz-Vélez
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

4.  Prevalence and associated factors of mental health outcomes among healthcare workers in Northern Colombia: A cross-sectional and multi-centre study.

Authors:  Hernan Felipe Guillen-Burgos; Janitza Gomez-Ureche; Carlos Renowitzky; Kaleb Acevedo-Vergara; Manuel Perez-Florez; Elizabeth Villalba; Jorge Escaf; Dieb Maloof; Riguey Torrenegra; Patricia Medina; Alberto Dau; Silvia Salva; Abdel Perez; Jesus Tapia; Soraya Salcedo; Ronald Maestre; Salvador Mattar; Miguel Parra-Saavedra; Jose Torres; Cesar Mesino; Nahir Acosta; Laura Mora; Gabriel Vega; Juan Francisco Galvez-Florez
Journal:  J Affect Disord Rep       Date:  2022-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.